Digoxin and Senolysis in Heart Failure and Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT06240403
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06240403
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06240403. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-01 (anticipated); primary completion 2028-08-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Digoxin and Senolysis in Heart Failure and Diabetes Mellitus
- Condition
- Heart Failure, Systolic
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Digoxin 0.125 MG
- Lead sponsor
- University of Leeds
Record details
- Record id
cardio:ct-nct06240403- Content hash
10c0f0edbbea61dd6da9421d37d328086b6c6dcd96f3fbc133068a6794135aa8